Dynavax (DVAX): Lub tuam txhab Biopharmaceutical yuav ntab Q4 qhia sai sai

Lub tuam txhab yuav tshaj tawm nws daim ntawv tshaj tawm Q4 ntawm hnub khwv tau thaum Lub Ob Hlis 23, 2023. Vanguard Group tau nce nws feem hauv lub tuam txhab los ntawm 3.60%. Dynavax Technologies Corp. is a biopharmaceutical c...

F-star Surges 60% Ntawm $ 161 Mln Tau Txais Kev Pom Zoo Los Ntawm Tuam Tsev Neeg Billionaire Sino Biopharmaceutical

Kev tau txais txiaj ntsig hauv kev txhim kho kev lag luam thiab cov nyiaj tau los tau hloov Tuam Tshoj mus rau hauv ib qho ntawm lub ntiaj teb kev lag luam loj tshaj plaws ... [+] rau cov kws tshuaj thiab cov khoom lag luam loj hlob hauv tsev. (Photo by Kevin F...

Late-Stage Biopharmaceutical Sierra Oncology tshaj tawm kev yuav los ntawm GSK

Sierra Oncology (NASDAQ: SRRA) sib koom ua lag luam ntau dua tom qab tshaj tawm qhov tau los ntawm GlaxoSmithKline PLC (LON: GSK) rau $ 55 ib feem ntawm nyiaj ntsuab. Qhov ntawd sawv cev rau tag nrho tus nqi sib npaug ntawm $ 1 ...